Live Breaking News & Updates on Alexander shoushtari

Stay informed with the latest breaking news from Alexander shoushtari on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Alexander shoushtari and stay connected to the pulse of your community

Novel immunotherapy approved for melanoma

Novel immunotherapy approved for melanoma
europeanpharmaceuticalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europeanpharmaceuticalreview.com Daily Mail and Mail on Sunday newspapers.

Philadelphia , Pennsylvania , United-states , Jason-bock , Frederick-vogt , Steven-rosenberg , Alexander-shoushtari , Iovance-biotherapeutics , National-cancer-institute , Cell-therapy-manufacturing-center , Drug-administration , Surgery-branch

Novel immunotherapy approved for melanoma

Amtagvi is the first tumour-derived autologous T cell immunotherapy therapy to be approved by the US Food and Drug Administration for certain adults with unresectable or metastatic...

Philadelphia , Pennsylvania , United-states , Jason-bock , Alexander-shoushtari , Frederick-vogt , Peter-marks , Steven-rosenberg , Iovance-biotherapeutics , Surgery-branch , Cell-therapy-manufacturing-center , National-cancer-institute

Natera Releases New Clinical Data at ESMO 2021 in Gastroesophageal Cancer and Uveal Melanoma

Natera Releases New Clinical Data at ESMO 2021 in Gastroesophageal Cancer and Uveal Melanoma
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

California , United-states , Dana-farber-cancer-institute , Massachusetts , Texas , San-carlos , Derek-klarin , Brandon-huffman , Mike-brophy , Kate-stabrawa , Alexey-aleshin , Alexander-shoushtari

Natera Releases New Clinical Data at ESMO 2021 in Gastroesophageal Cancer and Uveal Melanoma

Natera Releases New Clinical Data at ESMO 2021 in Gastroesophageal Cancer and Uveal Melanoma
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

California , United-states , Dana-farber-cancer-institute , Massachusetts , Texas , San-carlos , Derek-klarin , Brandon-huffman , Mike-brophy , Kate-stabrawa , Alexey-aleshin , Alexander-shoushtari

Reminder: Invitation to Targovax's Capital Markets Day 18 February 2021

Share this article
OSLO, Feb. 18, 2021 /PRNewswire/ --
Targovax ASA, a clinical stage immuno-oncology company developing immune activators to target hard-to-treat solid tumors, will host a virtual Capital Markets Day for investors, analysts and journalists today at 2:30 PM CET. The Capital Markets Day will feature presentations from executive management and Alexander Shousthari, Clinical Director Melanoma Services at Memorial Sloan Kettering Cancer Center, and will be webcast live and accessible at https://www.targovax.com/en/capital-markets-day-2021/

Based on the strong clinical data that are now generated on ONCOS-102, Targovax has a solid fundament to move into late stage clinical development. We also have a broader pipeline of preclinical assets that could create a broader horizon of opportunities in the future. The Capital Markets day will feature presentations updating the market on these aspects.

Norway , Alexander-shousthari , Victor-levitsky , Alexander-shoushtariis , Andreas-tinglum , Alexandern-shoushtari , Prnewswire-targovax , Renate-birkeli , Kim-sutton-golodetz , Corporate-communications-norway , Melanoma-services , Memorial-sloan-kettering-cancer-center